Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · Real-Time Price · USD
12.30
+0.05 (0.41%)
At close: Nov 22, 2024, 4:00 PM
12.28
-0.02 (-0.18%)
After-hours: Nov 22, 2024, 5:20 PM EST
Avid Bioservices Revenue
Avid Bioservices had revenue of $40.17M in the quarter ending July 31, 2024, with 6.49% growth. This brings the company's revenue in the last twelve months to $142.36M, down -5.28% year-over-year. In the fiscal year ending April 30, 2024, Avid Bioservices had annual revenue of $139.91M, down -6.27%.
Revenue (ttm)
$142.36M
Revenue Growth
-5.28%
P/S Ratio
5.48
Revenue / Employee
$383,714
Employees
371
Market Cap
786.66M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 139.91M | -9.36M | -6.27% |
Apr 30, 2023 | 149.27M | 29.67M | 24.81% |
Apr 30, 2022 | 119.60M | 23.73M | 24.75% |
Apr 30, 2021 | 95.87M | 36.17M | 60.58% |
Apr 30, 2020 | 59.70M | 6.10M | 11.38% |
Apr 30, 2019 | Pro | Pro | Pro |
Apr 30, 2018 | Pro | Pro | Pro |
Apr 30, 2017 | Pro | Pro | Pro |
Apr 30, 2016 | Pro | Pro | Pro |
Apr 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Embecta | 1.12B |
Pacira BioSciences | 694.96M |
Avanos Medical | 681.50M |
Prothena Corporation | 133.35M |
Cronos Group | 111.23M |
AbCellera Biologics | 32.96M |
Relay Therapeutics | 10.01M |
CDMO News
- 8 days ago - Punch and Associates sends letter to Board of Directors of Avid Bioservices, Inc. - Business Wire
- 13 days ago - AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc. - CDMO - Business Wire
- 15 days ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Avid Bioservices, Inc. - PRNewsWire
- 16 days ago - Avid Bioservices to be acquired by GHO and Ampersand for about $1.1 bln - Reuters
- 16 days ago - Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction - GlobeNewsWire
- 2 months ago - Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference - GlobeNewsWire
- 2 months ago - Avid Bioservices, Inc. (CDMO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 - GlobeNewsWire